0.795

10.09% 0.0441

Scinai Immunotherapeutics Ltd Adr (SCNI)

Overview News Price History Discussions Forecast Stock Split

Scinai Immunotherapeutics Ltd Adr stock is traded at $0.795, with a volume of 4,207. It is up +10.09% in the last 24 hours and down -31.11% over the past month. Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Previous Close:

$0.7509

Open:

$0.7601

24h Volume:

4,207

Relative Volume:

0.07

Market Cap:

$2.65M

Revenue:

Net Income/Loss:

$-9.29M

P/E Ratio:

-0.1529

EPS:

-5.2

Net Cash Flow:

$-9.42M

1W Performance:

+15.32%

1M Performance:

-31.11%

6M Performance:

-62.47%

1Y Performance:

-78.07%

1-Day Range:

$0.7601

$0.8342

1-Week Range:

$0.6906

$0.8342

52-Week Range:

$0.613

$6.18

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Company Profile

Name

Scinai Immunotherapeutics Ltd Adr

Sector

Healthcare (1126)

Industry

Biotechnology (624)

Phone

972-8-9302529

Address

JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM

Employee

Twitter

Next Earnings Date

Latest SEC Filings

SCNI's Discussions on Twitter

Compare SCNI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SCNI Scinai Immunotherapeutics Ltd Adr	0.7639	2.60M	0	-9.29M	-9.42M	-5.20
VRTX Vertex Pharmaceuticals Inc	467.92	113.87B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	773.55	80.22B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	405.75	52.56B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	801.69	49.31B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	174.75	37.37B	447.02M	-1.18B	-906.14M	-6.1812

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Latest News

Jan 02, 2026

Coca-Cola HBC (OTCMKTS:CCHGY) Trading 3.7% Higher – Should You Buy? - Defense World

Jan 02, 2026

PCCW (OTCMKTS:PCWLF) Trading Down 7.9% – Here’s Why - Defense World

Jan 02, 2026

Scinai Immunotherapeutics Ltd. Sponsored ADR (NASDAQ:SCNI) Sees Large Drop in Short Interest - Defense World

Jan 02, 2026

Dec 25, 2025

Scinai Immunotherapeutics (NASDAQ:SCNI) Stock Price Down 1.3% – Should You Sell? - Defense World

Dec 25, 2025

Dec 17, 2025

Revenue per share of Scinai Immunotherapeutics Ltd. Sponsored ADR – BER:2F5 - TradingView — Track All Markets

Dec 17, 2025

Dec 03, 2025

Scinai Immunotherapeutics (NASDAQ:SCNI) Shares Up 3% – What’s Next? - Defense World

Dec 03, 2025

Dec 02, 2025

Scinai Immunotherapeutics Reports Growth and Pipeline Progress - TipRanks

Dec 02, 2025

Scinai reports revenue growth as CDMO business expands By Investing.com - Investing.com India

Dec 02, 2025

Scinai reports revenue growth as CDMO business expands - Investing.com

Dec 02, 2025

Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances - Barchart.com

Dec 02, 2025

Dec 01, 2025

Revenue per share of Scinai Immunotherapeutics Ltd. Sponsored ADR – MUN:2F5 - TradingView

Dec 01, 2025

Nov 14, 2025

SCNI | Scinai Immunotherapeutics Ltd. ADR SEC Filings - MarketWatch

Nov 14, 2025

Nov 13, 2025

Scinai Immunotherapeutics schedules annual meeting for December 22 - Investing.com

Nov 13, 2025

Scinai Immunotherapeutics schedules annual meeting for December 22 By Investing.com - Investing.com South Africa

Nov 13, 2025

Cash per share of Scinai Immunotherapeutics Ltd. Sponsored ADR – BER:2F5 - TradingView

Nov 13, 2025

Oct 06, 2025

Scinai receives $246,000 grant to expand biotech manufacturing By Investing.com - Investing.com South Africa

Oct 06, 2025

Scinai receives $246,000 grant to expand biotech manufacturing - Investing.com

Oct 06, 2025

Sep 03, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) Reports First-Half 2025 Results, Strengthened Cash Position - Barchart.com

Sep 03, 2025

Sep 02, 2025

Scinai Reports Six-Month 2025 Financial Results Highlighting Continued CDMO Revenue Growth and Strengthened Balance Sheet - Barchart.com

Sep 02, 2025

Aug 26, 2025

Scinai Immunotherapeutics (NASDAQ:SCNI) Trading Down 3.8% – Here’s What Happened - Defense World

Aug 26, 2025

Jul 29, 2025